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ABSTRACT 95 
Background 96 
Crohn’s disease (CD) patients suffer from nutritional deficiencies when in active disease. We 97 
aim to examine calorific intake, macronutrient choice and disordered eating behaviour in 98 
patients with active CD.  99 
Methods  100 
CD patients with matched healthy volunteers (HV) were recruited. Active disease was defined 101 
by faecal calprotectin >250ug/g, C-reactive protein >5mg/dl, or active disease seen on 102 
endoscopy or imaging. Symptoms were quantified by Harvey-Bradshaw Index (HBI). Calorific 103 
intake was assessed by 24-h dietary recall. Disordered eating was assessed using validated 104 
questionnaires [Binge Eating Scale (BES); Power of Food Scale (PFS); Control of Eating 105 
Questionnaire (CoEQ); Dutch Eating Behaviour Questionnaire (DEBQ); Three Factor Eating 106 
Questionnaire (TFEQ)].  107 
Results  108 
30 CD (18M:12F, Age:32.3±2.19, BMI:24.9±0.8) and 31 matched HV (19M:12F, 109 
Age:32.8±2.0, BMI:24.7±0.5) were recruited. Mean faecal calprotectin was 110 
1032.5±176µg/g,C-reactive protein 83.8±47.1mg/L and HBI 4.8±1. There were no significant 111 
differences in calorific intake between groups. Protein intake was lower in the CD cohort 112 
(p=0.03). Hospital Anxiety and Depression score was higher (p=0.01) and CoEQ-Positive 113 
Mood (p=0.001) lower in CD. CD were characterised by higher BES (p=0.01) and lower CoEQ 114 
Craving Control (p=0.027) with greater craving for Sweet (p=0.043), Savoury (p=0.021) foods. 115 
PFS food present (p=0.005), DEBQ Emotional (p=<0.001) and External Eating (p=0.022) were 116 
significantly higher than HV.  117 
Conclusions   118 
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Reduced protein consumption and more prevalent disordered eating behaviour traits were 119 
present in CD. Greater binge eating and decreased control of cravings may be attributed to 120 
lower mood and higher anxiety observed. Patients may benefit from stronger psychological 121 
support with firm dietetic advice for healthy eating.  122 
Keywords 123 
Inflammatory Bowel Disease, Crohn’s disease, eating behaviour, nutrition  124 
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INTRODUCTION 141 
Patients with gastrointestinal disorders are at a greater risk of a disordered eating pattern 142 
compared to healthy volunteers with an increased prevalence of a wide range of abnormal 143 
eating patterns such as binge eating, meal skipping and food restriction 1,2. Disordered eating 144 
behaviour applies to most patients with gastrointestinal disease and may include food 145 
restriction, meal skipping and over-eating rather than the more severe eating disorders where 146 
patients are diagnosed according to specific narrow criteria 3,4. A disordered eating behaviour 147 
may be described with a two-path theoretical model 1,2. The first pathway concerns individuals 148 
who experience high levels of anxiety about unfamiliar foods and/or overestimate the negative 149 
consequences associated with their condition. These individuals may restrict their intake to 150 
self-prepared and familiar foods limiting their diet variety. The second pathway concerns 151 
individuals who gain weight when following their prescribed dietary regimen and subsequently 152 
employ techniques to reduce this weight gain.  153 
In Inflammatory Bowel Disease (IBD), issues regarding food intake are felt to be either 154 
important or extremely important in 62.5% of patients, with virtually all Crohn’s disease (CD) 155 
patients having had problems with unintentional weight loss 5. Abnormal eating patterns have 156 
been described in IBD with qualitative studies unselectively describing eating behaviour 157 
irrespective of disease activity 6,7. Approximately three-fourths of patients with IBD describe a 158 
decline in appetite when the disease is active 6 with up to 37% of CD patients showing 159 
abnormal eating patterns 8. Malnutrition is more prevalent in CD than ulcerative colitis with up 160 
to 75% of hospitalised patients being malnourished with 50% in negative nitrogen balance 9. 161 
To this effect, the IBD priority-setting partnership set up by the James Lind Alliance identified 162 
a research need to understand a role for diet in disease management 10. The effect of 163 
disordered eating on the nutritional status in CD has never been investigated.   164 
Appetite and satiety involve complex interactions between homeostatic and hedonic factors. 165 
The enteroendocrine-gut brain axis is central to the homeostatic control of food intake, whilst 166 
other neural circuits integrate environmental and emotional cues to constitute the hedonic 167 
8 
 
drive of appetite regulation 11. The cross-link between eating behaviour and active CD is poorly 168 
understood. Disordered eating might be associated with a change in the homeostatic and 169 
hedonic balance. The aim of this study is to examine free-living calorie and macronutrient 170 
intake in patients with active CD compared to healthy volunteers and to determine the 171 
prevalence and type of eating behaviour traits and disordered eating in CD patients with active 172 
disease.   173 
 174 
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METHODOLOGY  190 
Basic protocol and patient recruitment  191 
This was an open label, qualitative questionnaire-based study with a matched-pair design. 192 
The study was conducted between July 2015 and January 2018 at the National Institute of 193 
Health Research (NIHR) Nottingham Digestive Diseases Biomedical Research Centre (NDD 194 
BRC) at the Queens Medical Centre Campus, Nottingham, UK. Participants were recruited 195 
from The Inflammatory Bowel Disease Clinic, via the study flyer and social media. CD patients 196 
(aged 16-75yrs) with active disease were recruited as well as age, BMI and gender-matched 197 
healthy volunteers. Healthy volunteers (HV) were recruited form an existing participant 198 
database in the Nottingham BRC and from the local healthy populations of Nottingham 199 
University Hospitals and the University of Nottingham. This study was advertised through 200 
study fliers and social media.  201 
Disease activity was defined through objective markers of inflammation: faecal calprotectin of 202 
>250µg/g or CRP of >5g/dl or through recent ileocolonoscopy, CT or MR enterography 203 
showing active inflammatory and uncomplicated disease (not of a stricturing or penetrating 204 
behaviour). CD clinical activity was measured with a Harvey Bradshaw Index12 (HBI) score 205 
recorded at inclusion. Potential participants with recent corticosteroid use (in the last 3 206 
months), pregnancy or breast-feeding and patients with significant co-morbidities were 207 
excluded from the study. Stable doses of immunosuppressive agents or anti-TNF agents were 208 
permitted.  209 
All CD patients and healthy volunteers gave their informed consent prior to recruitment. 210 
Participants completed a single, spontaneously administered 24hr dietary recall either face-211 
to-face at the NDD BRC or by telephone, the Hospital Anxiety and Depression scale (HADS) 212 
and psychometric eating behaviour questionnaires within the study period.  213 
Outcomes 214 
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The primary outcome of this study was to compare total 24 hr calorie intake as measured by 215 
a single face-to-face or telephone-administered 24-hour dietary recall13 between CD with 216 
active disease and age-, BMI- and gender-matched HV. Calories consumed were calculated 217 
for the recall based on manufacturers’ labels and the nutrition analysis tool Nutritics (Nutritics 218 
v4.312 Academic Edition, Ireland). Dietary recall did not include caloric intake from weekends 219 
or holidays but only days Monday to Thursday. The secondary endpoint for this study was to 220 
measure eating behaviour traits through psychometric scales: Three Factor Eating 221 
Questionnaire (TFEQ) 14; the Binge Eating Scale 15; the Power of Food Scale 16; the Dutch 222 
Eating Behaviour Questionnaire 17; and the Control of Eating Questionnaire 18,19.  223 
24-h dietary recall  224 
The Automated Multiple-Pass Method (AMPM) was utilised to perform the single 225 
spontaneously administered 24hr dietary recall. This five-step questionnaire can accurately 226 
assess dietary consumption and may be administered face-to-face or by telephone 13,20 RW, 227 
AN and GT conducted all interviews. A copy of the dietary assessment textbook Carbs and 228 
Cals was provided to each participant to facilitate the dietary recall 21. This book contains over 229 
1700 food and drink photographs and was primarily used to assist in identifying the appropriate 230 
food type and portion size consumed. Diet logs were analysed using Nutritics dietary analysis 231 
software (Nutritics v4.312 Academic Edition, Ireland). 232 
Eating Behaviour traits 233 
Eating behaviour traits were measured through five validated self-report questionnaires; the 234 
Power of Food Scale (PFS); the Binge Eating Scale (BES); the Control of Eating Questionnaire 235 
(COEQ); Three Factor Eating Questionnaire (TFEQ) and the Dutch Eating Behaviour 236 
Questionnaire (DEBQ) 14-18.  237 
 238 
The Power of Food Scale (PFS)  239 
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The PFS is a 15-item questionnaire reflecting the psychological influence of the food 240 
environment. It measures appetite for, rather than consumption of palatable foods and may 241 
be a useful measure of the hedonic impact of food environments replete with highly palatable 242 
foods 22. Items are grouped into three domains according to food proximity; food available but 243 
not physically present, food present but not tasted and food tasted but not consumed.  244 
The Binge Eating Scale (BES)  245 
The BES is a 16-item questionnaire that assesses the severity of binge eating tendencies. 246 
Eight questions describe the behavioural manifestations of binge eating behaviour and eight 247 
describe the feelings and cognitions associated with binge eating. Scores are summed to 248 
produce a total score ranging from 0 to 46. Cut off points have previously been reported 249 
denoting mild (≤17), moderate (18–26), and severe (≥27) binge eating behaviour 15,23,24. 250 
The Control of Eating Questionnaire (CoEQ)  251 
The CoEQ is a 21-item questionnaire designed to assess the severity and type of food 252 
cravings experienced over the previous seven days 18. The CoEQ has four subscales; Craving 253 
Control, Craving for Savoury, Craving for Sweet and Positive Mood. Items on the CoEQ are 254 
assessed by 100-mm visual analogue scales (VAS) with items relating to each subscale being 255 
averaged to create a final score. 256 
Three Factor Eating Questionnaire (TFEQ) 257 
The TFEQ contains 51-items and measures three dimensions of human eating behaviour; 258 
Cognitive Restraint of Eating, Disinhibition and Hunger 14. Restraint refers to concern over 259 
weight control and strategies which are adopted to achieve this. Disinhibition reflects a 260 
tendency towards over-eating and eating opportunistically in an obesogenic environment. 261 
Hunger is concerned with the extent to which hunger feelings are perceived and the extent to 262 
which such feelings evoke food intake 25. Each item scores either 0 or 1 point. The minimum 263 
score for factors I, II and III is therefore 0, with the possible maximum scores being 21, 16 264 
and14 respectively.   265 
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The Dutch Eating Behaviour Questionnaire (DEBQ)  266 
The 33-item DEBQ assesses different eating styles that may contribute to weight gain; 267 
emotional eating, external eating, and restraint. ‘Emotional eating’ occurs in response to 268 
emotional arousal states such as fear anger or anxiety, ‘external eating’ in response to external 269 
food cues such as sight and smell of food and ‘restraint eating’ is overeating after a period of 270 
slimming when the cognitive resolve to diet is abandoned 17. 271 
Statistical Analysis  272 
The sample size was based on published data 26 where the 24hr self-reported calorie intake 273 
in CD was 1978.7±169.7Kcal and that in HV was 1854.4 ±129.5Kcal. Assuming α of 0.05, 274 
power of 80% and using 2-sided test, 30 participants in each group were needed to show a 275 
significant difference in the primary outcome.  276 
Data were analysed using SPSS version 20 for Windows. The parametric or non-parametric 277 
nature of the data was determined by a normality test. Data is presented as mean ± standard 278 
error of the mean (SEM). Continuous data was compared using paired t-test while categorical 279 
data was compared with Chi-Squared test. Total 24hr Kcal intake, macronutrient intake 280 
together with outcome data from the individual questionnaires administered to all participants 281 
were compared between the groups. An exploratory sub-analysis was undertaken comparing 282 
differences between gender. P values <0.05 were deemed significant.  283 
Ethical approval  284 
This study received research ethics committee approval from National Research Ethics 285 
Service (NRES) Committee East Midlands (REC reference 15/EM/0142 as of the 27th April 286 
2015). The protocol was registered with clinical trials.gov (NTC02379117). 287 
RESULTS  288 
Demographic data 289 
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Thirty CD patients (18M:12F, Age:32.3±2.19, BMI:24.9±0.8) and 31 matched HV (19M:12F, 290 
Age:32.8±2.0, BMI:24.7±0.5) were recruited to this matched pairs cross-sectional study (see 291 
Table 1). There were no significant differences in gender ratio, mean age and mean BMI 292 
between the CD and HV. CD participants had objective evidence of active disease with an 293 
elevated C-reactive protein (83.8±47.1mg/L), or faecal calprotectin (1032.5±176µg/g) or as 294 
assessed by colonoscopy or MR enterography or both (see supplementary table). These 295 
objective investigations have been undertaken as part of the participants standard of care 296 
within a mean of 52.9±14.1 days of recruitment. Mean HBI score was 4.8±1. None of the 297 
participants had any change in management prior to recruitment and data collection. Upon 298 
recruitment, 10 participants (33.3%) were being prescribed immunosuppressant therapy, 6 299 
(20%) anti-TNF therapy and 7 (23.3%) CD participants a combination of anti-TNF therapy and 300 
immunosuppressant therapy. Eleven participants (36%) had a history of CD-related intestinal 301 
surgery with a mean of 0.4±0.1 CD-related operations per patient. Mean disease duration prior 302 
to recruitment was 8.1±1.5 years. 303 
Table 1: Summary demographic data of participants 304 
Group Gender (n) Age  BMI 
CD M (18) 31.1±2.7  24.1±1.1  
 F (12) 34.1±3.8  26.1±1.2  
    
HC M (19) 32.6±2.3 24.7±0.6 
 F (12)  33±3.9 24.8±1.0 
 305 
24-hour calorie intake 306 
The total self-reported 24-hour calorie and macronutrient intake for the CD and HV cohorts 307 
are shown in Table 2. There were no significant differences observed in total energy intake 308 
between cohorts. Protein intake was significantly lower in the CD cohort (CD, 70.3g±6.1; HV, 309 
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92.6g±7.8p=0.03). There was no significant difference in the consumption of all other 310 
macronutrients.   311 
In a sub-analysis of this dataset aimed at investigating difference by gender, the 24hr calorie 312 
intake of male CD participants was not significantly different to male HV participants. In female 313 
participants, 24-hour calorie intake was significantly reduced in the CD cohort compared with 314 
HV participants (CD, 1519.3±136.5; HV, 2039.4Kcal±133.8; p=0.01).  In female participants 315 
consumption of carbohydrate (CD, 187.9g±19.9 HV, 270.1g±22.3, p=0.01), sugar (CD, 316 
78.9±8.5; HV, 107.5±9.3; p=0.03) and fibre (CD, 15.9g±2.6; HV, 25.9g±3.8; p=0.04) were 317 
significantly less than in HV participants.  318 
 319 
Table 2. 24-hour self-reported calorie and macronutrient intake in CD and HV. Data is 320 
presented as mean and Standard error of the mean 321 
 CD  
(total) 
CD  
(male) 
CD 
(female) 
HV  
(total) 
HV  
(male) 
HV  
(female) 
Total (Kcal) 1900.9± 
138.6 
2187.0± 
193.7 
1519.3± 
136.5 
2054.3± 
110.7 
 
2065.0± 
167.0 
2039.4± 
133.8 
Carbohydrate (g) 248.4±  
20.7 
 
 
293.7± 
28.5 
187.9± 
19.9 
255.9± 
17.3 
 
245.9± 
25.3 
270.1± 
22.3 
Sugar (g) 97.8± 
8.1 
 
112.0± 
11.6 
78.9± 
8.5 
101.7± 
7.4 
 
97.6± 
10.9 
107.5± 
9.3 
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Protein (g) 70.3± 
6.1 
 
74.0± 
8.5 
65.4± 
8.8 
92.6± 
7.8 
 
101.6± 
12.2 
79.9± 
6.8 
 
Fat (g) 69.7± 
6.2 
 
79.4± 
8.2 
56.9± 
8.3 
72.3± 
5.3 
 
73.8± 
8.1 
70.2± 
6.2 
Saturated Fat (g) 23.1± 
2.1 
 
26.2± 
2.5 
18.9± 
3.3 
 
23.1± 
2.2 
 
23.6± 
3.4 
 
22.5± 
2.5 
Fibre (g)  18.9 ±  
2.1 
 
21.2± 
3.0 
15.9± 
2.6 
23.4± 
2.3 
21.7± 
2.8 
25.9± 
3.8 
Alcohol (g) 3.5± 
1.8 
 
5.0± 
2.9 
1.5± 
1.5 
 
4.6± 
1.9 
 
5.5± 
2.8 
 
3.4± 
2.2 
 322 
Hospital Anxiety and Depression Scale 323 
CD participants had significantly higher scores on the Hospital Anxiety and Depression scale 324 
compared to HV participants (CD, 13.4±1.6; HV, 7.4±1.5; p=0.01) (see Table 3). This was 325 
evident for both anxiety (CD, 8.6±0.9; HV, 4.2±0.7; p=0.001) and depression (CD, 6±0.9; HV, 326 
1.8±0.3; p=<0.001) subscales.  327 
Both male (CD 13.5±2.1; HV, 4.3±1; p=0.001) and female (CD, 15.9±2.9; HV, 8.6±1.6; p=0.04) 328 
CD participants showed significant difference in HADS when compared with HV participants. 329 
Male CD participants scored significantly higher than HV participants in both anxiety (CD 330 
7.9±1.2; HV, 2.9±0.7; p=0.002) and depression (CD 5.5±1.2; HV, 1.3±0.4; p=0.005) 331 
subscales. Female participants however were only significantly different in the depression 332 
subscale (CD 6.5±1.5; HV, 2.5±0.6; p=0.02).  333 
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Eating Behaviour traits 334 
Table 3 shows the outcomes from the psychometric eating behaviour questionnaires for CD 335 
and HV. CD participants scored higher on BES compared to HV participants (CD, 10.9±1.9; 336 
HV, 5.2±1.0; p=0.01) and a greater proportion of CD participants (29%) scored above the 337 
clinical cut-off criteria for moderate levels of binge eating (>17 BES) compared to HV (3.3%) 338 
[χ2 (1) = 7.0, p=0.008].  339 
CD participants reported lower levels of CoEQ Craving Control (CD, 56.16±3.5; HV, 66.4±2.9; 340 
p=0.027) and greater craving for sweet (CD, 48.9±4.4; HV, 37.3±3.5; p=0.043) and savoury 341 
(CD, 48.9±3.5; HV, 38.3±2.7; p=0.021) foods compared to HV participants. CD participants 342 
scored significantly lower on the CoEQ Positive Mood subscale (CD, 50.8±3.3; HV, 64.8±2.5; 343 
p=0.001). 344 
CD participants had higher scores on the PFS food present (CD, 11.7±0.7; HV, 9.0±0.6; 345 
p=0.005) subscale. No significant difference was seen however for overall PFS score or food 346 
available or tasted subscales.  347 
In addition, CD participants scored higher on the DEBQ Emotional Eating (CD, 36.4±3.7; HV, 348 
20.0±1.7; p=<0.001) and External Eating (CD, 30.8±1.9; HV, 25.2±1.2; p=0.022) subscales 349 
compared to HV participants. However, there was no difference in restraint assessed by either 350 
or DEBQ (CD, 23.7±2.7; HV, 21.6±1.9; p=0.528) the TFEQ (CD, 6.4±0.9; HV, 8.4±0.9; p=NS) 351 
between CD and HV participants.  352 
 353 
Table 3. Eating behaviour traits in CD participants and age-, BMI- and gender-matched HV.  354 
 CD HV Sig. (2-tailed) 
HADS 13.4±1.6 
 
7.4±1.5 
 
0.01 
HADS: Anxiety 8.6±0.9 4.2±0.7 0.001 
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HADS: Depression 6.0±0.9 1.8±0.3 <0.001 
 
BES 10.9±1.9 
 
5.2±1.0 
 
0.01 
PFS 35.6±2.4 
 
31.0±1.9 
 
NS 
PFS: Available 12.1±1.2 
 
10.5±0.9 
 
NS 
PFS: Present 11.7±0.7 9.0±0.6 0.005 
 
PFS: tasted 11.7±0.8 
 
11.7±0.8 
 
NS 
CoEQ: Control 56.2±3.5 66.4±2.9 
 
0.027 
CoEQ: Sweet 48.9±4.4 37.3±3.5 
 
0.043 
CoEQ: Savoury 48.9±3.5 38.2±2.7 
 
0.021 
CoEQ: Mood 50.7±3.3 64.8±2.5 
 
0.001 
TFEQ: R 5.9±0.9 8.4±0.9 
 
NS 
TFEQ: D 6.1±0.8 4.5±0.6 
 
NS 
TFEQ: H 5.5±0.8 4.0±0.5 NS 
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DEBQ: R 23.7±2.7 21.6±1.9 NS 
 
DEBQ: Em 36.4±3.7 20.0±1.7 
 
<0.001 
DEBQ: Ex 30.8±1.9 25.2±1.2 0.022 
 
 355 
When analysed by gender, male CD participants showed significant difference in BES (CD, 356 
7.3±1.6; HV, 3.4±0.8; p=0.04) CoEQ: Control (CD 58.9±4.4; HV, 70.5±3.3; p=0.04) CoEQ: 357 
Sweet (CD, 51.5±6.2; HV, 32.9±4.1; p=0.01), TFEQ: Restraint (CD, 4.1±0.8; HV, 8.3±1.1; 358 
p=0.005) and DEBQ: Emotional (CD, 31.4±4.2; HV, 18.9±1.9; p=0.02) when compared with 359 
male HV participants.  360 
Female CD participants showed significant difference in PFS: Present (CD, 12.8±1; HV, 9.6±1; 361 
p=0.04), CoEQ: Mood (CD, 44.1±5.2; HV, 64.1±4.1; p=0.006) and DEBQ: Emotional (CD, 362 
43.8±6; HV, 22±3.4; p=0.01) when compared with female HV participants.  363 
 364 
 365 
 366 
 367 
 368 
 369 
DISCUSSION  370 
A poor nutritional status has always been associated with CD but a detailed analysis of eating 371 
behaviour in this cohort compared to matched HV has never been undertaken. The primary 372 
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aim of this study was to compare the total self-reported 24 hr calorie intake in CD with active 373 
disease and HV. The main secondary aim was to examine whether CD participants with active 374 
disease had a greater prevalence of disordered eating patterns compared to HV.  We found 375 
no substantial difference in the 24-hour self-reported calorie intake between CD participants 376 
with objective evidence of intestinal inflammation and age-, BMI- and gender-matched HV 377 
participants. Analysing the data further by gender reveals that a significant decrease in calorie 378 
intake is observed in female rather than male CD participants with this reduction in food intake 379 
consisting mainly of a reduction in carbohydrates in females and protein in males.  This finding 380 
is novel and contrasts with observations made in previous studies that have showed no 381 
difference in energy intake in CD patients with both active and inactive disease 27,28. These 382 
differences in food intake may be explained by the two-path theoretical model; with CD 383 
patients experiencing high levels of anxiety to food intake, thus restricting food variety to 384 
minimise symptom aversion 1,2.  385 
An increased prevalence of disordered eating behaviour traits was observed in CD with a 386 
greater prevalence of binge eating, food craving, lower mood and higher anxiety states 387 
observed in this group. Patients with gastrointestinal disorders are reported to suffer from 388 
disordered eating behaviour with more than a third of CD patients thought to be affected 8. In 389 
the present study, it was demonstrated that CD participants scored significantly higher on 390 
measures of binge eating and hedonic responsiveness compared to HV participants. Binge 391 
eating traits were more prevalent as revealed by a significantly higher BES together with 392 
significantly stronger cravings with less ability of self-control. The CoEQ showed that CD 393 
participants had less control of their cravings, with significantly greater cravings for both sweet 394 
and savoury foods.  395 
Significantly higher scores on the hedonic eating traits (i.e. BES, PFS, DEBQ-External) in CD 396 
may be associated with increased food monitoring behaviour that occurs in patients with 397 
dietary-controlled conditions. These findings are consistent with previous research that have 398 
demonstrated a higher level of disordered eating patterns in individuals with gastrointestinal 399 
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disorders 1,2. In a questionnaire-based study in 400 consecutive IBD patients in the UK 6, 400 
approximately half of the patients felt that diet was the initiating factor in IBD and subsequent 401 
relapses. The majority of patients’ symptoms were triggered by food with two-thirds of the 402 
patients depriving themselves of their favourite food to achieve symptom control. A case-403 
control study of 104 patients with an established diagnosis of IBD 29 concluded that avoidance 404 
of meat, nuts, fruit and vegetables are more common among patients with IBD than healthy 405 
controls. This corresponds with the findings of this study where the consumption of protein 406 
was significantly reduced overall and carbohydrate, sugar and fibre intake were reduced in 407 
females.  408 
The current study also demonstrated that CD participants had lower levels of positive mood 409 
as measured by the CoEQ and higher scores on the HAD scale. Greater levels of 410 
psychological distress have been linked to increased binge eating prevalence and in the 411 
current study we found that scores on the BES were negatively associated with positive mood 412 
(data not shown). Similarly, we found a higher prevalence of emotional eating in the DEBQ. 413 
These findings have important implications for the role of mood and psychological distress in 414 
the aetiology of gastrointestinal disorders and their association with abnormal eating patterns 415 
30.  For example, it is possible that psychological distress may serve as both a cause and a 416 
consequence of disordered eating behaviours 3. Arigo et al suggested that fear and anxiety 417 
surrounding gastrointestinal symptoms may lead to disordered eating practices of a restrictive 418 
nature, as observed in this study 31. This increased anxiety may link directly to the personal 419 
attitudes and beliefs that patients hold about food. In a French survey of 244 IBD patients, 420 
nearly half of the study patients reported that the disease had changed the pleasure of eating 421 
7 with only a quarter of the patients eating a normal diet when they relapse. Such a behaviour 422 
influenced patients’ social life in 25% of the cases. This might have a negative effect on mood 423 
and depressive symptoms.  424 
Disease activity has been quantified with objective markers of disease activity and intestinal 425 
inflammation present in our entire recruited cohort. Clinical scores were quantified through 426 
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HBI.  Gastrointestinal symptom severity may also play an important role in the development 427 
of disordered eating patterns, with greater symptom severity correlating positively with the risk 428 
of disordered eating 32.  429 
When analysed by gender, female CD participants consumed significantly less calories than 430 
female HV participants with reduced consumption of carbohydrate, sugar and fibre. This was 431 
not observed in male participants. Male CD participants displayed greater hedonic 432 
responsiveness with higher BES, lower CoEQ Control and TFEQ:Restraint compared with 433 
male HV participants. In female CD participants, significantly higher PFS: present and DEBQ: 434 
Emotional with lower CoEQ: mood when compared with female HV participants might imply 435 
that female CD participants may be predisposed to emotional eating. These results may 436 
suggest that female CD participants have similar level of self-control over dietary consumption 437 
as HV. Consequently, females with CD may be less likely to binge eat during active disease, 438 
being more likely to display inadequate calorie consumption as displayed by this study. Male 439 
CD participants display greater hedonic responsiveness, with higher prevalence of binge 440 
eating with the consequence of normalising calorie consumption. It is important to highlight 441 
that this study was not powered to analyse the difference in eating behaviour by gender, so 442 
such conclusions are hypothesis-generating.  443 
We believe that for the first time, this study highlights in detail the important behavioural 444 
differences that may be observed in patients with active CD. This study has some limitations 445 
that need to be considered. This was a prospective study aiming to compare calorific intake 446 
and the eating behaviour of CD patients with active disease to matched healthy volunteers. 447 
The BMI of the recruited cohort was BMI:24.9±0.8 in CD and 24.7±0.5 in HV participants. 448 
These values are at the upper limit of what the World Health Organisation considers as normal 449 
weight. Nevertheless, these BMIs are representative of present world-wide trends making our 450 
cohorts more representative 33 34. The sample size despite being relatively small was 451 
appropriately powered based on the group’s previous pilot data 26. Daily activity level is an 452 
important confounder that was not routinely measured to try and minimise participant research 453 
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burden. Physical inactivity has already been shown in CD 35,36 and has been significantly 454 
correlated to disease activity but is still prevalent in remission 37. Due to the small sample size, 455 
we did not investigate the effect of disease burden surrogates: disease duration, concomitant 456 
medication and surgical history in CD patients on eating behaviour.  The effect of these 457 
variables on eating behaviour should be investigated in downstream studies. Nevertheless, 458 
the CD cohort recruited is representative of a CD cohort with moderate disease burden, 459 
making our findings generalizable to world-wide healthcare systems.  460 
The use of the AMPM as a single administered 24-hour recall is limited, and accuracy may 461 
have been improved if this was performed on three consecutive days rather than one day. 462 
However, this method has been used successfully in previous research 20. The 24-hour recall 463 
technique is also memory dependent and participants’ potential bias in reporting “good/bad” 464 
foods may affect the accuracy of the outcome. In this study, the 24-hour recall data was 465 
collected by three interviewers, which may have introduced inter-rater variability in the data 466 
collected. Additionally, during dietary recall, if a manufacturer’s nutritional label was not 467 
available, portion size was obtained using the Carbs and Cals textbook as a visual aid, which 468 
may have affected the estimation of portion size. When assessing eating behaviours, the use 469 
of multiple behavioural questionnaires may have introduced an element of participant fatigue 470 
that may have decreased the specificity of the responses given. The order of these 471 
questionnaires was administered randomly to all participants throughout the study to mitigate 472 
this risk. Future studies should use additional methods such as weighed food records, and 473 
laboratory test meals to measure food intake in patients with active CD and to confirm the 474 
caloric intake findings of the present study.  475 
Biochemical, endoscopic and radiological objective measures of disease activity have been 476 
acquired as part of routine standard of care rather than as a specific screening process for 477 
this study. For this reason, there was a variable lag between the dates of these assessments 478 
and recruitment to this study. None of these patients changed their maintenance therapy after 479 
these investigations and prior to recruitment within this study.  480 
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In conclusion, this study has highlighted the significantly higher prevalence of emotional eating 481 
and food monitoring behaviour in CD. Clinically these results imply that stronger psychological 482 
and firm dietetic education may be of benefit in CD. Nearly half of the IBD patients have never 483 
received dietetic advice and two-thirds feel they need more support 6. Questioning patients on 484 
their attitudes and beliefs through counselling or psychotherapy may alter these behaviours. 485 
Firm dietetic advice for healthy eating should also be advocated. Additionally, combating 486 
underlying anxiety and depression in these patients may improve disordered eating traits. The 487 
UK IBD standards in 2013 highlighted the need for formal psychological support in IBD teams 488 
with only 24% of adult IBD services have defined access to a psychologist with an interest in 489 
IBD 38.  490 
This study has provided new evidence regarding the complexity of disordered eating 491 
behaviour traits in active CD. A more objective understanding is needed regarding the fine 492 
balance between homeostatic and hedonic control of food intake in intestinal inflammation.  493 
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 SEX AGE 
(YR.) 
BMI 
(KG/M2) 
MONTREAL DIS. 
DUR. 
(YR.) 
MED HBI CRP  
(MG/L) 
FCP 
(µG/G)  
MRI COLONOSCOPY 
P01 F 48 24.9 A1L3B2 41 Nil 4 - - - Post op recurrence Rutgeerts i3 
P02 M 22 21.8 A2L1B3 3 AZA 2 - - - Post op recurrence Rutgeerts i3 
P03 M 51 21.4 A2L1B2 18 HUM,
MTX 
1 - 316 multifocal active small bowel 
disease 
 
P04 F 23 26.7 A2L3B1 4 AZA 5 - - - Diffuse punched out ulcerations in 
terminal ileum 
P05 M 30 25.5 A2L3B3 10 Nil 9 - - - Colonoscopy  - Rutgeerts i2 
P06 M 25 26.2 A2L3B1 6 HUM 2 - 1763 - - 
P07 M 23 20 A2L3B3 1 HUM 11 - - 30cm of TI disease with an 
enter-enteric fistula 
- 
P08 F 37 24.3 A2L1B2 14 Nil 9 - - Terminal ileitis - 
P10 F 23 23.1 A2L1B1 1 MP 5 - - - Diffuse punched out ulcerations in 
terminal ileum 
P11 M 35 33.7 A2L3B1p 2 HUM 9 52 - - rectosigmoid inflammation with a 
perianal fistula 
P13 F 29 36 A2L1B1 10 Nil 7 - - 6cm terminal ileum 
inflammatory disease 
- 
P14 M 32 29.6 A2L3B3p 14 HUM,
AZA,P 
5 - - pancolonic inflammatory 
disease with distal sparing. 
Has a desc colon stricture. 
Distal 3cm TI inflamed 
- 
P15 M 57 18.6 A3L1B3 15 AZA,P 10 - - mixed inflammatory and 
stricturing disease in the ileum 
- 
P16 F 33 24.9 A2L2B1 13 INF, 
AZA 
6 - 449 - severe colonic disease with puynched 
out ulcers 
P17 F 40 27.6 A3L1B3 0 Nil 5 - - 30cm of terminal ileal 
inflammatory disease 
- 
P19 M 49 25.7 A3L3B1 1 P 2 - - 15cm of terminal ileal 
inflammatory disease 
- 
P20 
M 33 22.5 A2L3L4B2 8 INF, 
AZA 
0 - 
1800 
extensive jejunal disease - 
P23 
M 20 19.37 A2L3B3 4 MP 7 - - - Post op recurrence Rutgeerts i2 
P24 
M 28 18.6 A2L1B1 1 Nil 3 - - - 
Diffuse punched out ulcerations in 
terminal ileum 
P25 
M 23 23.4 A2L3B1p 1 AZA 1 
- - Diffuse terminal ileal 
inflammatory disease 
- 
P26 
M 38 30.6 A2L3B2 11 AD, 
AZA 
8 
- 785 - 
- 
P27 
F 35 30.3 A2L2B2 
 
13 HUM 8 
- 1226  
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P28 
F 22 23 A2L1 B2 
 
7 HUM, 
AZA 
0 
38   
Ruterts i2 
P29 
M 20 19.3 A2L2B1 
 
3 AZA 4 
- 1027  
 
P30 
F 68 21.4 A3L2B2/B3 
 
1 MTX 8 
224 - extensive transverse colonic 
disease with fistulisation 
 
P31 
M 31 25.5 A2L1B1 
 
9 AD 1 
- 607 chronic disease 
 
P32 
F 28 30 A2L2B1 
 
4 INF, 
MP 
1 
- 319  
 
P33 
F 24 22 A2L2 B1 
 
12 HUM 1 
- -  
mild patchy colitis with loss of vascular 
pattern, erythema in R colon. 
P34 
M 25 29.7 A2L1B1 
 
9 MP 2 
- 1800 Thickening of the terminal 
ilium 
 
P35 
M 18 22 A2L2B1 
 
6 MP 8 
- 1266  
 
 
       
   
 
  Supplementary Table: CD Participant Demographic  
AD=ADALIMUMAB, AZA=AZATHIOPRINE, HUM=HUMIRA, INF=INFLIXIMAB, MP=MERCAPTOPURINE, MTX=METHOTREXATE, P=PENTASA 
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